Febuxostat Versus Allopurinol Control Trial in Subjects With Gout

NCT00102440 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

760

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Febuxostat
DRUG: Febuxostat
DRUG: Allopurinol

Sponsor

Takeda